The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

List includes medications for diabetes, cancer, arthritis, and more ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Centers for Medicare & Medicaid Services (CMS) announced that Botox is among 15 prescription drugs newly added to the ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

A recent U.S. Court of Appeals for the Third Circuit ruling upholding the federal Inflation Reduction Act (IRA)’s drug price ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...